EcoDrugPlus

Lysyl Oxidase-Like 2b

Ensembl ID : ENSPMAG00000004547
Gene Symbol: LOXL2B
1 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSPMAG00000004231
Gene Symbol: MIF
1 Cross references
233 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSPMAG00000002690
Gene Symbol: MMP2
1 Cross references
209 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSPMAG00000000713
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSPMAG00000008658
Gene Symbol: MTNR1AA
1 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSPMAG00000009252
Gene Symbol: MAPK1
1 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSPMAG00000000656
Gene Symbol: MAPK10
1 Cross references
500 Possible Orthologues:

Mitogen-Activated Protein Kinase 14a

Ensembl ID : ENSPMAG00000008420
Gene Symbol: MAPK14A
1 Cross references
11 Possible Orthologues:

Mitogen-Activated Protein Kinase 8a

Ensembl ID : ENSPMAG00000003756
Gene Symbol: MAPK8A
1 Cross references
500 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSPMAG00000008016
Gene Symbol: NPR3
2 Cross references
210 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSPMAG00000003838
Gene Symbol: NTSR1
2 Cross references
282 Possible Orthologues:

Opioid Receptor Mu 1

Ensembl ID : ENSPMAG00000001376
Gene Symbol: OPRM1
2 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).